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James D Kean1, David Camfield1, Jerome Sarris1,2, Marni Kras1, Richard Silberstein1, Andrew Scholey1 and Con Stough1*The authors have identified an error in this published
article [1].
On page 4, under “Treatments” the milligrams listed
have been calculated incorrectly. The sentence:
“The Lyprinol capsules contain 18% EPA (46.8 mg)
and 14% DHA (36.4 mg) per capsule.”
Should read:
“The Lyprinol capsules contain approximately 14%
EPA (7.3 mg) and 11% DHA (5.5 mg) per capsule.”
We apologize for this error.
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